Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,281.0
3.0 (0.09%)

 

  • STI Straits Times Index
    3,281.0
    3.0 (0.09%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,595.8
    7.9 (0.50%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    29,056.4
    173.4 (0.60%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,075.5
    1.4 (0.05%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    24,041.3
    108.1 (0.45%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,291.7
    5.6 (0.09%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,250.6
    2.5 (0.11%)
    Index delayed 20 minutes
  • XAO XAO
    7,180.3
    21.7 (0.30%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,723.5M
  • Value: 1,021.1M
  • Rise: 204
  • Fall: 116
  • Unch: 499

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
AsiaPhos0.047+0.019
Golden Agri-Res0.235-
OEL0.029+0.009
Sincap0.013+0.003
Rex Intl0.192+0.011
AusGroup^0.048+0.001
BlackGoldNatural0.018+0.002
AsiaMedic0.013+0.002
Ley Choon0.022+0.004
GCCP0.009+0.002

World Indices

World Indices
Name Last Change
Nasdaq 9,388.9 +31.8
HSI 29,056.4 +173.4
HSCEI 11,419.9 +91.5
Jakarta 6,291.7 +5.6
Nikkei 225 24,041.3 +108.1
SSE Comp 3,075.5 +1.4
Shanghai A 3,222.5 +1.4
Shanghai B 260.1 +2.0
PSE Comp 0.0
KOSPI 2,250.6 +2.5

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

CIRC CIRC
Quotes 15 Minutes Delayed. Updated at 17 Jan 2020 16:08
Last (HKD): 22.500 Change: +1.050 High: 24.600 Remarks: -
Change (%): +4.90 Low: 21.150
Open 21.450 Yesterday's Close 21.450
Buy Price 22.500 Sell Price 22.500
Buy Volume ('000) 11.4 Sell Volume ('000) 69.2
Cumulative Volume ('000) 746.6 Cumulative Value 16,855,520
Click to show Stock Prices chart

Key Statistics

EPS (HKD) a 1.19584 Trailing EPS (HKD) e 1.26965 NAV (HKD) b 12.6730
PE a 18.815 Trailing PE f 17.721 Price / NAV b 1.7754
Dividend (HKD) d 0.308769 Cash In Hand (HKD) g 6.3284 Issued & Paid-up Shares c 79,968,800
Dividend Yield (%) d 1.372 Price / Cash In Hand g 3.555 Treasury Shares h -
Beta - 75 Daysi 0.318 R-Squared - 75 Days(%)i 1.34 Market Cap (M) 7,197.183
Beta - 500 Daysi 0.769 R-Squared - 500 Days (%)i 14.18 Enterprise Value (M) 5,935.248
Piotroski F Score 7 Exchange Code 1763 Par Value ( CNY ) 1.00000
52 Weeks Volatility (%) 25.16 6-Month VWAP 20.672 Free Float (%) 45.3
Sector & Industry Health Technology - Medical Specialties
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 06 Aug 2018.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 29 Jun 2018.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference CIRC HKEx 7,197.183 18.815 17.721 1.7754 1.372
Industry Medical Specialties HKEx 5,824.657 49.357 34.629 2.6178 0.669
Local Peer WEIGAO GROUP HKEx 45,178.077 25.896 22.331 2.5673 1.141
Local Peer MICROPORT HKEx 15,676.055 83.644 30.459 4.0263 0.296
Local Peer AK MEDICAL HKEx 13,411.398 78.121 57.374 12.3593 0.272
Local Peer VENUS MEDTECH-B HKEx 8,130.818 - - - -
Local Peer LIFETECH SCI HKEx 6,813.933 47.505 40.517 4.3950 -
Local Peer YESTAR HEALTH HKEx 3,403.613 11.415 10.751 2.5321 -
Local Peer GOLDEN MEDITECH HKEx 2,275.205 - - 0.5546 -
Local Peer PW MEDTECH HKEx 2,244.028 16.501 14.335 0.4326 -
Local Peer KDL MEDICAL HKEx 1,791.700 - - - -
Local Peer MODERN DENTAL HKEx 1,464.819 17.155 13.707 0.7240 2.227
Local Peer MY MEDICARE HKEx 1,008.295 - - -29.1139 -
Local Peer YUNNAN ENERGY HKEx 815.294 - - 2.8788 -
Other Local Peers KELFRED (HKEx), VINCENT MED (HKEx), LIFE HEALTHCARE (HKEx), COMBEST HOLD (HKEx), HUAKANG BIOMED (HKEx), CH DEMETER FIN (HKEx)
Global Peer MEDTRONIC PLC NYSE 159,545.431 34.452 34.171 3.1544 1.748
Global Peer ABBOTT LABORATORIES NYSE 157,298.600 66.850 48.089 4.9438 1.295
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 136,012.137 46.294 37.865 4.6334 0.216
Global Peer DANAHER CORP NYSE 117,122.900 44.182 48.177 3.7901 0.383
Global Peer STRYKER CORP NYSE 79,436.448 22.358 23.186 6.4504 0.910
Global Peer BECTON DICKINSON & CO NYSE 74,939.057 - - - -
Global Peer INTUITIVE SURGICAL INC NASDAQ 69,347.867 61.484 52.772 8.9350 -
Global Peer BOSTON SCIENTIFIC CORP NYSE 61,718.350 36.935 56.622 6.3633 -
Global Peer EDWARDS LIFESCIENCES CORP NYSE 49,773.145 68.919 64.331 13.0474 -
Global Peer BAXTER INTERNATIONAL INC NYSE 45,812.190 28.209 28.958 5.8643 0.817
Other Global Peers ZIMMER BIOMET HOLDINGS INC (NYSE), IDEXX LABORATORIES INC (NASDAQ), RESMED INC (NYSE), ALIGN TECHNOLOGY INC (NASDAQ), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), DEXCOM INC (NASDAQ), METTLER-TOLEDO INTERNATIONAL INC (NYSE), TELEFLEX INC (NYSE), COOPER COS INC (NYSE), WATERS CORP (NYSE), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), HOLOGIC INC (NASDAQ), VARIAN MEDICAL SYSTEMS INC (NYSE), DENTSPLY SIRONA INC (NASDAQ), STERIS PLC (NYSE), INSULET CORPORATION (NASDAQ), WEST PHARMACEUTICAL SERVICES INC (NYSE), BIO RAD LABORATORIES INC (NYSE), PERKINELMER INC (NYSE), COCHLEAR LTD (ASX), NOVOCURE LTD (NASDAQ), MASIMO CORPORATION (NASDAQ), FISHER & PAYKEL HEALTHCARE CORP (ASX), BRUKER CORPORATION (NASDAQ), ABIOMED INC (NASDAQ), QIAGEN NV (NYSE), HILL-ROM HOLDINGS INC (NYSE), HAEMONETICS CORP (NYSE), PENUMBRA INC (NYSE), GLOBUS MED INC (NYSE), ENVISTA HOLDINGS CORPORATION (NYSE), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), HARTA (Bursa), NUVASIVE INC (NASDAQ), TANDEM DIABETES CARE INC (NASDAQ), ICU MEDICAL INC (NASDAQ), WRIGHT MEDICAL GROUP NV (NASDAQ), NEOGEN CORP (NASDAQ), NEVRO CORP (NYSE), LIVANOVA PLC (NASDAQ), CONMED CORP (NASDAQ), QUIDEL CORP (NASDAQ), TOPGLOV (Bursa), Top Glove (SGX), CANTEL MEDICAL CORP (NYSE), EBOS GROUP (ASX), GLAUKOS CORPORATION (NYSE), IRHYTHM TECHNOLOGIES INC (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), INSPIRE MEDICAL SYSTEMS INC (NYSE), STAAR SURGICAL CO (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), BIOTELEMETRY INC (NASDAQ), AVANOS MEDICAL INC (NYSE), ATRICURE INC (NASDAQ), NANOSONICS LIMITED (ASX), INMODE LTD (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), ATRION CORP (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), NATUS MEDICAL INC (NASDAQ), MESA LABORATORIES INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), CRYOLIFE INC (NYSE), INOGEN INC (NASDAQ), AXONICS MODULATION TECHNLOGS INC (NASDAQ), CAREDX INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), HESKA CORP (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), VERICEL CORP (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), QUOTIENT LTD (NASDAQ), ANGIODYNAMICS INC (NASDAQ), CERUS CORP (NASDAQ), AXOGEN INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), SURMODICS INC (NASDAQ), SI BONE INC (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), CUTERA INC (NASDAQ), VIEWRAY INC (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), OXFORD IMMUNOTEC GLOBAL PLC (NASDAQ), SUPERMX (Bursa), MEDICAL DEVELOPMENT INTL (ASX), MCP INCOME OPPORTUNITIES TRUST (ASX), TRANSMEDICS GROUP INC (NASDAQ), CORMEDIX INC (NYSE American), SEASPINE HOLDINGS CORP (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), UTAH MEDICAL PRODUCTS (NASDAQ), SIENTRA INC (NASDAQ), ZYNEX INC (NASDAQ), STEREOTAXIS INC (NYSE American), BIOLIFE SOLUTIONS INC (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), RTI SURGICAL HOLDINGS INC (NASDAQ), MISONIX INC (NASDAQ), IRADIMED CORP (NASDAQ), INVACARE CORP (NYSE), FLUIDIGM CORP DEL (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), ACCURAY INCORPORATED (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), GENMARK DIAGNOSTICS INC (NASDAQ), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), APYX MEDICAL CORPORATION (NASDAQ), VAPOTHERM INC (NYSE), SOLITON INC (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), VENUS CONCEPT INC (NASDAQ), TELA BIO INC (NASDAQ), INTRICOM CORP (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), PROFOUND MED CORP (NASDAQ), CYTOSORBENTS CORP (NASDAQ), FONAR CORP (NASDAQ), DERMTECH INC (NASDAQ), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), SOMNOMED LIMITED (ASX), BIOSIG TECHNOLOGIES INC (NASDAQ), ONCOCYTE CORP (NYSE American), ENLIVEX THERAPEUTICS LTD (NASDAQ), CONFORMIS INC (NASDAQ), MRI INTERVENTIONS INC (NASDAQ), COMPUMEDICS (ASX), NEURONETICS INC (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), ELECTROMED INC (NYSE American), RESONANCE HEALTH LTD (ASX), NEMAURA MEDICAL INC (NASDAQ), ELLEX MEDICAL LASERS LTD (ASX), NEPHROS INC (NASDAQ), SDI LTD (ASX), STRATA SKIN SCIENCES INC (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), CYCLOPHARM LIMITED (ASX), MOTUS GI HOLDINGS INC (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), PAVMED INC (NASDAQ), IMPEDIMED LIMITED (ASX), MILESTONE SCIENTIFIC INC (NYSE American), ALPHA PRO TECH (NYSE American), RETRACTABLE TECHNOLOGIES INC (NYSE American), ADMEDUS LTD (ASX), IRIDEX CORP (NASDAQ), Biolidics (SGX), ELECTROCORE INC (NASDAQ), DAXOR CORP (NYSE American), CELSION CORPORATION (NASDAQ), OVENTUS MEDICAL LTD (ASX), ENDOLOGIX INC (NASDAQ), IMMUCELL CORP (NASDAQ), EMVISION MEDICAL DEVICES LTD (ASX), IMPRESSION HEALTHCARE LIMITED (ASX), Yunnan Energy (SGX), EKSO BIONICS HOLDINGS INC (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), BIOMERICA INC (NASDAQ), NEOVASC INC (NASDAQ), RESPIRI LTD (ASX), MICRO-X LTD (ASX), LBT INNOVATIONS LTD (ASX), XTANT MEDICAL HLDGS INC (NYSE American), BELLEROPHON THERAPEUTICS INC (NASDAQ), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), NANOVIBRONIX INC (NASDAQ), BIOLASE INC (NASDAQ), ADVENTA (Bursa), RA MEDICAL SYSTEMS INC (NYSE), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), Medtecs Intl (SGX), TITAN MEDICAL INC (NASDAQ), UG Healthcare (SGX), OBJ LIMITED (ASX), DARIOHEALTH CORP (NASDAQ), DIMERIX LTD (ASX), LKL (Bursa), CHECK-CAP LTD (NASDAQ), CARDIEX LTD (ASX), NEUROTROPE INC (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), CYANOTECH CORP (NASDAQ), OBALON THERAPEUTICS INC (NASDAQ), USCOM LTD (ASX), ATOSSA THERAPEUTICS INC (NASDAQ), ALLEGRA ORTHOPAEDICS LIMITED (ASX), PREDICTIVE ONCOLOGY INC (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), Annica (SGX), OPTISCAN IMAGING (ASX), AVINGER INC (NASDAQ), HANCOCK JAFFE LABORATORIES INC (NASDAQ), INSPIREMD INC (NYSE American), IMAGION BIOSYSTEMS LIMITED (ASX), LIANLUO SMART LIMITED (NASDAQ), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), TENAX THERAPEUTICS INC (NASDAQ), DYNATRONICS CORP (NASDAQ), ANALYTICA (ASX), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), MICRON SOLUTIONS INC (NYSE American), AETHLON MEDICAL INC (NASDAQ), VALERITAS HOLDINGS INC (NASDAQ), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), DIGIRAD CORP (NASDAQ), STHAI (SET), CHF SOLUTIONS INC (NASDAQ), NEUROMETRIX INC (NASDAQ), ADHERIUM LIMITED (ASX), VIVEVE MEDICAL INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), METALICITY LIMITED (ASX), MEDIGARD LIMITED (ASX), AKERS BIOSCIENCES INC (NASDAQ), NEUROTECH INTERNATIONAL LTD (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.950
+4.41 %
10 Days -+1.500
+7.14 %
20 Days -+2.050
+10.02 %
Medium Term Return 3 Months -+2.500
+12.50 %
6 Months -+3.960
+21.36 %
1 Year 0.139+7.580
+51.74 %
Annualised Return Annualised --
+51.74 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 14.400 - 24.600 Change From 1 Year Low +8.100 % Change From 1 Year Low (%) +56.25
Change From 1 Year High -2.100 % Change From 1 Year High (%) -8.54
2 Years Range 12.700 - 24.600 Change From 2 Years Low +9.800 % Change From 2 Years Low (%) +77.17
Change From 2 Years High -2.100 % Change From 2 Years High (%) -8.54
5 Years Range 12.700 - 24.600 Change From 5 Years Low +9.800 % Change From 5 Years Low (%) +77.17
Change From 5 Years High -2.100 % Change From 5 Years High (%) -8.54
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

China Isotope & Radiation Corp. engages in the research, development, manufacturing and sale of diagnostic and therapeutic radiopharmaceuticals and radioactive source products for medical and industrial applications. It also offers irradiation service for sterilization purpose and EPC service for the design, manufacturing and installation of gamma ray irradiation facilities, independent clinical laboratory services to hospitals and other medical institutions. The company has following four business segments: Pharmaceuticals, Radioactive source products, irradiation, independent clinical laboratory services and other businesses. China Isotope & Radiation was founded in 1983 and is headquartered in Beijing, China.

Historical Price Data

Date Open High Low Close Volume VWAP
17 Jan 2020 21.450 24.600 21.150 22.500 746,600 22.5764
16 Jan 2020 21.150 21.500 21.150 21.450 65,800 21.3128
15 Jan 2020 21.550 21.750 21.100 21.550 187,200 21.4835
14 Jan 2020 21.300 21.650 21.200 21.500 95,800 21.5307
13 Jan 2020 21.600 21.600 21.100 21.150 78,200 21.4277
10 Jan 2020 21.400 21.600 21.200 21.550 120,000 21.4313
09 Jan 2020 21.050 21.550 21.000 21.400 102,200 21.3385
08 Jan 2020 20.700 21.600 20.700 21.000 228,000 21.3013
07 Jan 2020 20.650 21.500 20.550 20.700 406,432 20.8735
06 Jan 2020 21.000 21.050 20.500 20.750 109,400 20.8248
03 Jan 2020 21.100 21.150 20.500 21.000 169,460 20.7992
02 Jan 2020 21.000 21.050 20.650 20.650 120,600 20.8403
31 Dec 2019 21.350 21.650 21.000 21.050 9,800 21.1541
30 Dec 2019 20.600 21.500 20.600 21.500 118,800 21.0442
27 Dec 2019 21.150 21.750 20.550 20.550 128,800 20.7572
24 Dec 2019 21.150 21.150 21.150 21.150 200 21.1500
23 Dec 2019 20.850 21.200 20.800 21.150 40,300 21.0034
20 Dec 2019 20.250 20.800 20.250 20.450 575,552 20.2721
19 Dec 2019 20.300 20.500 20.150 20.350 20,600 20.2272
18 Dec 2019 20.300 20.300 20.300 20.300 21,000 20.3000
17 Dec 2019 20.100 20.450 19.980 20.300 236,800 20.0111
16 Dec 2019 20.200 20.600 20.050 20.350 121,400 20.3694
Summary
Current 2 Weeks
(06 Jan 2020 to 17 Jan 2020)
21.000 24.600 20.500 22.500 2,139,632 -
Previous 2 Weeks
(18 Dec 2019 to 03 Jan 2020)
20.300 24.600 20.300 21.000 1,205,112 -
4 Weeks from
(20 Nov 2019 to 17 Dec 2019)
21.150 24.600 20.500 20.300 2,478,526 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.